Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel hemostatic alternatives in reconstructive surgery.

Milton Waner1

  • 1Department of Otolaryngology, University of Arkansas for Meedical Sciences, Little Rock, AR, USA.

Seminars in Hematology
|February 12, 2004
PubMed
Summary

Severe congenital vascular lesions pose surgical bleeding risks. New hemostatic agents, like recombinant activated factor VII (rFVIIa), offer improved control during reconstructive surgery for these challenging vascular malformations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Unique Presentation of Focal Auricular Arteriovenous Malformation: from Embryology to Angiosome Theory.

Facial plastic surgery & aesthetic medicine·2025
Same author

Advantages of Early Surgical Management of Periorbital Infantile Hemangiomas.

Facial plastic surgery & aesthetic medicine·2024
Same author

Outcome of bleomycin electrosclerotherapy of slow-flow malformations in adults and children.

European radiology·2024
Same author

American society of pediatric otolaryngology vascular anomalies task force review of tongue venous malformations: Techniques, pearls, and pitfalls.

International journal of pediatric otorhinolaryngology·2023
Same author

Distribution and Clinical Characteristics of Periorbital Infantile Hemangiomas.

Facial plastic surgery & aesthetic medicine·2022
Same author

Reconstruction after ablative treatment of arteriovenous malformations of the head and neck.

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·2022

Area of Science:

  • Vascular Surgery
  • Pediatric Surgery
  • Hematology

Background:

  • Congenital vascular lesions are classified as hemangiomas, vascular malformations, or tumors.
  • Severe lesions historically presented high surgical bleeding risks, limiting treatment options.

Observation:

  • Topical hemostatic agents have limitations in severe bleeding or in patients with coagulation disorders.
  • Recombinant activated factor VII (rFVIIa) has emerged as a systemic hemostatic agent.

Findings:

  • The paper reviews advancements in hemostasis for congenital vascular lesions.
  • It discusses the efficacy of rFVIIa in managing intraoperative bleeding during reconstructive surgery.

Implications:

  • Improved hemostatic strategies enhance surgical outcomes for patients with severe vascular lesions.

Related Experiment Videos

  • Further research into placental origins of hemangiomas may inform future treatments.